These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34240624)
21. Dynamic m6A modification regulates local translation of mRNA in axons. Yu J; Chen M; Huang H; Zhu J; Song H; Zhu J; Park J; Ji SJ Nucleic Acids Res; 2018 Feb; 46(3):1412-1423. PubMed ID: 29186567 [TBL] [Abstract][Full Text] [Related]
22. Glutathione-Bioimprinted Nanoparticles Targeting of N6-methyladenosine FTO Demethylase as a Strategy against Leukemic Stem Cells. Cao K; Du Y; Bao X; Han M; Su R; Pang J; Liu S; Shi Z; Yan F; Feng S Small; 2022 Apr; 18(13):e2106558. PubMed ID: 35119204 [TBL] [Abstract][Full Text] [Related]
23. Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. Chen B; Ye F; Yu L; Jia G; Huang X; Zhang X; Peng S; Chen K; Wang M; Gong S; Zhang R; Yin J; Li H; Yang Y; Liu H; Zhang J; Zhang H; Zhang A; Jiang H; Luo C; Yang CG J Am Chem Soc; 2012 Oct; 134(43):17963-71. PubMed ID: 23045983 [TBL] [Abstract][Full Text] [Related]
24. Identification of Clausine E as an inhibitor of fat mass and obesity-associated protein (FTO) demethylase activity. Wang Y; Li J; Han X; Wang N; Song C; Wang R; Chang J J Mol Recognit; 2019 Oct; 32(10):e2800. PubMed ID: 31321808 [TBL] [Abstract][Full Text] [Related]
25. Identification of Natural Compound Radicicol as a Potent FTO Inhibitor. Wang R; Han Z; Liu B; Zhou B; Wang N; Jiang Q; Qiao Y; Song C; Chai J; Chang J Mol Pharm; 2018 Sep; 15(9):4092-4098. PubMed ID: 30063141 [TBL] [Abstract][Full Text] [Related]
26. Structure-Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors. Liu Z; Duan Z; Zhang D; Xiao P; Zhang T; Xu H; Wang CH; Rao GW; Gan J; Huang Y; Yang CG; Dong Z J Med Chem; 2022 Aug; 65(15):10638-10654. PubMed ID: 35793358 [TBL] [Abstract][Full Text] [Related]
27. FTO in Lung Cancer: Its Progression and Therapeutic Potential. Chen XF; Gong C Comb Chem High Throughput Screen; 2024; 27(15):2301-2307. PubMed ID: 38485681 [TBL] [Abstract][Full Text] [Related]
28. When will small molecule lactate dehydrogenase inhibitors realize their potential in the cancer clinic? Rani R; Kumar V Future Med Chem; 2017 Jul; 9(11):1113-1115. PubMed ID: 28722474 [No Abstract] [Full Text] [Related]
29. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation. Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349 [TBL] [Abstract][Full Text] [Related]
30. Solution structure ensemble of human obesity-associated protein FTO reveals druggable surface pockets at the interface between the N- and C-terminal domain. Khatiwada B; Nguyen TT; Purslow JA; Venditti V J Biol Chem; 2022 May; 298(5):101907. PubMed ID: 35398093 [TBL] [Abstract][Full Text] [Related]
31. The Role of FTO in Tumors and Its Research Progress. Wei H; Li Z; Liu F; Wang Y; Ding S; Chen Y; Liu J Curr Med Chem; 2022; 29(5):924-933. PubMed ID: 34269659 [TBL] [Abstract][Full Text] [Related]
32. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314 [TBL] [Abstract][Full Text] [Related]
33. Single-Molecule Counting of FTO in Human Breast Tissues Based on a Rolling Circle Transcription Amplification-Driven Clustered Regularly Interspaced Short Palindromic Repeat─Cas12a. Wang ZY; Li DL; Tian X; Li Y; Zhang CY Anal Chem; 2022 Aug; 94(32):11425-11432. PubMed ID: 35916620 [TBL] [Abstract][Full Text] [Related]
34. Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties. Xiao P; Duan Z; Liu Z; Chen L; Zhang D; Liu L; Zhou C; Gan J; Dong Z; Yang CG J Med Chem; 2023 Jul; 66(14):9731-9752. PubMed ID: 37418628 [TBL] [Abstract][Full Text] [Related]
35. FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma. Xiao L; Li X; Mu Z; Zhou J; Zhou P; Xie C; Jiang S Cancer Res; 2020 Sep; 80(18):3945-3958. PubMed ID: 32680921 [TBL] [Abstract][Full Text] [Related]
36. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway. Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587 [TBL] [Abstract][Full Text] [Related]
37. SIRT1 Regulates N Liu X; Liu J; Xiao W; Zeng Q; Bo H; Zhu Y; Gong L; He D; Xing X; Li R; Zhou M; Xiong W; Zhou Y; Zhou J; Li X; Guo F; Xu C; Chen X; Wang X; Wang F; Wang Q; Cao K Hepatology; 2020 Dec; 72(6):2029-2050. PubMed ID: 32154934 [TBL] [Abstract][Full Text] [Related]
38. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer. Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548 [TBL] [Abstract][Full Text] [Related]
39. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression. Song W; Yang K; Luo J; Gao Z; Gao Y Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172 [TBL] [Abstract][Full Text] [Related]
40. Calmodulin as Ca Marcinkowski M; Pilžys T; Garbicz D; Piwowarski J; Przygońska K; Winiewska-Szajewska M; Ferenc K; Skorobogatov O; Poznański J; Grzesiuk E Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639211 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]